Table 4 The system time and saved time for end users

1

hsa-miR-1231

cell movement

2.51

10

62 %

55 %

61 %

2

hsa-miR-1288-5p

cell proliferation

2.89

9

61 %

51 %

62 %

3

hsa-miR-143-3p

mitosis

5.54

10

61 %

52 %

60 %

4

hsa-miR-192-5p

leukemic infiltration

2.24

8

53 %

53 %

59 %

5

hsa-miR-216a-5p

drug resistance,

4.09

11

65 %

55 %

62 %

multiple

6

hsa-miR-29c-3p

recurrence

8.99

11

68 %

53 %

63 %

7

hsa-miR-3155a

dna cleavage

1.21

6

53 %

47 %

55 %

8

hsa-miR-320b

drug resistance

17.59

18

73 %

51 %

66 %

9

hsa-miR-3622a-5p

entosis

0.30

6

51 %

43 %

57 %

10

hsa-miR-371b-5p

mitochondrial

3.89

12

66 %

59 %

64 %

dynamics

11

hsa-miR-3934-5p

dna methylation

0.93

8

61 %

45 %

59 %

12

hsa-miR-4263

mutagenesis

1.65

6

52 %

46 %

56 %

13

hsa-miR-4431

mitochondrial

0.17

6

53 %

47 %

55 %

degradation

14

hsa-miR-4505

cell transformation,

4.25

10

63 %

55 %

61 %

neoplastic

15

hsa-miR-4648

cell polarity

0.71

6

52 %

45 %

57 %

16

hsa-miR-4700-3p

neoplasm regression,

1.56

7

53 %

51 %

59 %

spontaneous

17

hsa-miR-4756-5p

endocytosis

3.76

10

67 %

53 %

62 %

18

hsa-miR-4802-3p

drug resistance,

1.67

7

55 %

47 %

59 %

microbial

19

hsa-miR-501-3p

insulin resistance

1.78

8

57 %

43 %

61 %

20

hsa-miR-520a-3p

ubiquitination

13.31

17

75 %

55 %

65 %

Average

—————

—————

3.95

9.30

60.05 %

50.30 %

60.15 %